These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15500999)

  • 1. Partial solubility parameters of poly(D,L-lactide-co-glycolide).
    Schenderlein S; Lück M; Müller BW
    Int J Pharm; 2004 Nov; 286(1-2):19-26. PubMed ID: 15500999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation.
    Pavanetto F; Genta I; Giunchedi P; Conti B
    J Microencapsul; 1993; 10(4):487-97. PubMed ID: 8263677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
    Young TJ; Johnston KP; Mishima K; Tanaka H
    J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation variables on the morphology of biodegradable microparticles prepared by spray drying.
    Clarke N; O'Connor K; Ramtoola Z
    Drug Dev Ind Pharm; 1998 Feb; 24(2):169-74. PubMed ID: 15605447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple measurements for prediction of drug release from polymer matrices - Solubility parameters and intrinsic viscosity.
    Madsen CG; Skov A; Baldursdottir S; Rades T; Jorgensen L; Medlicott NJ
    Eur J Pharm Biopharm; 2015 May; 92():1-7. PubMed ID: 25668778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation.
    Thomasin C; Merkle HP; Gander B
    J Pharm Sci; 1998 Mar; 87(3):269-75. PubMed ID: 9523977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
    J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X; Bodmeier R
    J Control Release; 2006 Jan; 110(2):266-272. PubMed ID: 16300851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering the drug release profiles of double-layered ternary-phase microparticles.
    Lee WL; Loei C; Widjaja E; Loo SC
    J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and in-vitro degradation of polylactide and poly(L-lactide-co-glycolide)].
    Wei Z; Liu L; Zhang M; Yang F; Qi M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):122-6. PubMed ID: 18435272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis.
    Murillo M; Irache JM; Estevan M; Goñi MM; Blasco JM; Gamazo C
    Int J Pharm; 2004 Mar; 271(1-2):125-35. PubMed ID: 15129979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submicronparticles from biodegradable polymers.
    Jobmann M; Rafler G
    Int J Pharm; 2002 Aug; 242(1-2):213-7. PubMed ID: 12176249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
    Wang SH; Liang ZH; Zeng S
    Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.